2018 Enterocolitis Drug Development- Pipeline Analysis Report

  • ID: 4527595
  • Report
  • 40 pages
  • VPA Research
1 of 4

FEATURED COMPANIES

  • Cancer Advances Inc
  • Effexus Pharmaceutical
  • Il-Yang Pharm.Co.,Ltd
  • New Haven Pharmaceuticals
  • RaQualia Pharma Inc
  • Rottapharm
  • MORE
Necrotizing enterocolitis (NEC) is a devastating inflammatory bowel disease which can completely damage the intestine walls, causing holes in the intestine and leak out of stool into abdomen. The highly infectious disease occurs predominantly in premature infants. An estimated 10,000 births are affected in the US.

Around 10 companies and universities are focusing on developing treatment options for Enterocolitis.

To assist investigators and funding and regulatory organizations, the publisher has come up with a comprehensive report on Enterocolitis pipeline. The report provides insights into different therapeutic candidates in preclinical, research, discovery, NDA/IND, pre registration, phase 1, phase 2, and phase 3 trials). Drugs under development directly and through combination with other drugs are also included.

Current status, developmental phase, participating companies and entities, recent developments, orphan drug/ fast track/ other designations, drug class are provided for each Enterocolitis pipeline product. Mechanism of Action and the target area of the pipeline product are also provided. Further, clinical and preclinical trials along with results of the trials are also included in the report.

In addition to complete details of each product, the report provides key trends in Enterocolitis pipeline studies. The products under development are categorized according to their development phase, mechanism and company to provide detailed insights into the type of drugs being developed and the stages of development.
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Cancer Advances Inc
  • Effexus Pharmaceutical
  • Il-Yang Pharm.Co.,Ltd
  • New Haven Pharmaceuticals
  • RaQualia Pharma Inc
  • Rottapharm
  • MORE
1.1 List of Figures
1.2 List of Tables

2 Enterocolitis Pipeline Analysis
2.1 Disease and Pipeline Overview
2.2 Enterocolitis Pipeline Snapshot
2.3 Enterocolitis Pipeline by Phase
2.4 Enterocolitis Pipeline by Company
2.5 Enterocolitis Pipeline by Mechanism of Action

3 Enterocolitis- Company Wise Pipeline Analysis
  • Avexegen Therapeutics
  • Glycosyn LLC
  • Infant Bacterial Therapeutics
  • Leadiant Biosciences
  • ProMetic Life Sciences
4 Enterocolitis R&D Pipeline Snapshots
  • Drug wise Pipeline Details
  • Therapeutic Candidate Name
  • Originator
  • Co-Developer/ License Partner
  • Orphan Drug Designation
  • Development Phase
  • Mechanism of Action
  • Current Status
  • Ongoing Clinical Trial Details
5 Recent Developments in Enterocolitis Pipeline

6 Appendix
6.1 About the Publisher
6.2 Sources and Research Methodology

1.1 List of Figures
Figure 1: Enterocolitis Pipeline by Phase, H1- 2018
Figure 2: Enterocolitis Pipeline by Companies, H1- 2018
Figure 3: Company Wise Pipeline Drug Phases, H1- 2018
Figure 4: Enterocolitis Pipeline by Mechanism of Action, H1- 2018
Figure 5: Mechanism Wise Pipeline Drug Phases, H1- 2018

1.2 List of Tables
Table 1: Enterocolitis Pipeline by Phase, H1- 2018
Table 2: Enterocolitis Pipeline by Companies, H1- 2018
Table 3: Enterocolitis Pipeline by Mechanism of Action, H1- 2018
Table 4: Avexegen Therapeutics Enterocolitis Pipeline, May 2018
Table 5: Glycosyn LLC Enterocolitis Pipeline, May 2018
Table 6: Infant Bacterial Therapeutics Enterocolitis Pipeline, May 2018
Table 7: Leadiant Biosciences Enterocolitis Pipeline, May 2018
Table 8: ProMetic Life Sciences Enterocolitis Pipeline, May 2018
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • Cancer Advances Inc
  • CJ HealthCare
  • Daewoong Pharmaceutical Co
  • Effexus Pharmaceutical
  • Eisai Co Ltd
  • Il-Yang Pharm.Co.,Ltd
  • Ironwood Pharmaceuticals
  • Jeil Pharmaceutical Co Ltd
  • Jiangsu Aosaikang Pharmaceutical
  • Mitsubishi Pharma Corporation
  • New Haven Pharmaceuticals
  • Pfizer
  • RaQualia Pharma Inc
  • Renexxion LLC
  • Rottapharm
  • Takeda Pharmaceutical Co
  • Trio Medicines Ltd
  • Yooyoung Pharm Co Ltd
  • Yuyu Pharma Inc
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll